Fox, E. J., et al.. Msj808189_supplementary_tables – Supplemental Material for Ocrelizumab Reduces Progression of Upper Extremity Impairment in Patients with Primary Progressive Multiple Sclerosis: Findings from the Phase III Randomized ORATORIO Trial. Figshare, Nov. 2018, doi:10.25384/sage.7343696.